机构:[1]National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, ChineseAcademy of Medical Sciences and Peking Union Medical College, Beijing,China,[2]Cancer Center, Union Hospital, Tongji Medical College, HuazhongUniversity of Science and Technology, Wuhan, China,华中科技大学同济医学院附属协和医院[3]National CancerCenter/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) andPeking Union Medical College (PUMC), Center for Cancer Precision Medicine, CAMS and PUMC, Beijing, China,[4]Department of Radiation Oncology, The General Hospital of Chinese People's Liberation Army, Beijing,China,[5]Beijing Hospital, Beijing, China,[6]The Affiliated Provincial Hospitalof Anhui Medical University, Hefei, China,[7]Department of RadiationOncology, Fujian Medical University Union Hospital, Fuzhou, China,[8]Peking Union Medical College Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, China,[9]Department of Radiation Oncology, the Fourth Hospital of Hebei MedicalUniversity, Shijiazhuang, China,[10]Jiang Xi Province Cancer Hospital, Nanchang, China,[11]Zhejiang Cancer Hospital, Hangzhou, China,浙江省肿瘤医院[12]The University of Texas MD Anderson Cancer Center, Houston, TX,[13]Department ofRadiation Oncology, Fujian Provincial Cancer Hospital, Fuzhou, China,[14]Department of Lymphoma, Affiliated Hospital of Guizhou Medical University, Guizhou Cancer Hospital, Guiyang, China,[15]Department of Radiation Oncology, Hunan Cancer Hospital and the Affiliated Cancer Hospital ofXiangya School of Medicine, Changsha, China,[16]Department of RadiationOncology, Xijing Hospital, Air Force Medical University, Xi'an, China,[17]Tianjin Medical University Cancer Institute & Hospital, Key Laboratory ofCancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin, China,[18]Department of Radiation Oncology, Cancer Hospitaland Institute, Chinese Academy of Medical Sciences (CAMS) and PekingUnion Medical College (PUMC), Beijing, China,[19]Department of Oncology,307 Hospital, Academy of Military Medical Science, Beijing, P. R. China,Beijing, China,[20]Peking University Cancer Hospital & Institute, Beijing,China,[21]Sun Yat-sen University Cancer Center, State Key Laboratory ofOncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China,[22]Department of Radiation Center, ChongqingUniversity Cancer Hospital & Chongqing Cancer Institute & ChongqingCancer Hospital, Chongqing, China,[23]Affiliated Hospital of Qinghai University, Xining, China,[24]aaa, aaa, Antarctica,[25]Department of RadiationOncology, National Cancer Center/National Clinical Research Center forCancer/Cancer Hospital, Chinese Academy of Medical Sciences and PekingUnion Medical College, Beijing, China
出处:
ISSN:
语种:
外文
WOS:
中科院分区:
出版当年[2022]版:
大类|1 区医学
小类|2 区核医学2 区肿瘤学
最新[2025]版:
大类|1 区医学
小类|2 区肿瘤学2 区核医学
JCR分区:
出版当年[2022]版:
Q1ONCOLOGYQ1RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
最新[2024]版:
Q1ONCOLOGYQ1RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
第一作者机构:[1]National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, ChineseAcademy of Medical Sciences and Peking Union Medical College, Beijing,China,
推荐引用方式(GB/T 7714):
X. Zheng,L.L. Zhang,X. Liu,et al.Pattern and Prognosis of Distant Metastases in Patients with Early-Stage Extranodal Nasal-Type NK/T-Cell Lymphoma[J].INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS.2022,114(3):E349-E350.
APA:
X. Zheng,L.L. Zhang,X. Liu,B.L. Qu,Q.Z. Zhong...&Y.X. Li.(2022).Pattern and Prognosis of Distant Metastases in Patients with Early-Stage Extranodal Nasal-Type NK/T-Cell Lymphoma.INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS,114,(3)
MLA:
X. Zheng,et al."Pattern and Prognosis of Distant Metastases in Patients with Early-Stage Extranodal Nasal-Type NK/T-Cell Lymphoma".INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 114..3(2022):E349-E350